| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |